PubMed Health⌕ Search

Biomedical subjects

Ailton Melo

Publications and source records attributed to Ailton Melo.

At least 19 recordsLinked to original sources

Does botulinum toxin decrease frequency and severity of sialorrhea in Parkinson's disease?

This study analysed if botulinum toxin type A (BTX-A) decreases drooling in 21 Parkinson's disease patients. BTX-A injections were given in the parotid glands. The severity of drooling decreased in 18 (86%) patients, while frequency was reduced in 8 (38%). In 11(52%) patients, the frequency of drooling remained constant, which may reflect more difficulties in swallowing, compared to the group that presented such improvement. Future trials assessing the level of swallowing dysfunction may be important to establish a prognosis for patients who keep the frequency of drooling in spite of decreased severity after BTX injection.

Aged↗

[Role of patent foramen ovale and of the Eustaquian valve in the trhomboembolic events].

The association between patent foramen ovale (PFO) and paradoxical emboli is described in medical literature. When have not association with atrial septal aneurysm, arguments arise about the clots origin, because it have been difficult to gave evidence of the clots passing from venous circulation across shunt right to left. We describe four cases of vascular events whose transesophageal echocardiography showed clots nailed within the PFO associated the prominent Eustachian valve, without septal aneurysm. This paper aim to illustrate and to warm about the potentially role of the PFO and Eustachian valve in the paradoxical embolism.

Adult↗

Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy.

Muscle overactivity, one of the cardinal features of spasticity, is a common sequel of cerebral palsy. In this group of patients spasticity is responsible for several limitations that interfere with gait, causing variable functional disability. Drugs such as baclofen, tizanidine, or benzodiazepines, or even definitive treatments such as orthopedics or neurosurgeries are generally prescribed with uncertain results. The use of botulinum toxin type A has been frequently suggested for the treatment of spastic equinus foot in cerebral palsy, but few studies with adequate methodology support this idea. The present paper reviews and summarizes the data of published double-blind, randomized clinical trials to assess, with a meta-analysis, if botulinum toxin type A is an adequate treatment for spasticity caused by cerebral palsy. The results reveal a statistical superiority of botulinum toxin type A over placebo on gait improvement, tested using the Physician Rating Scale and Video Gait Analysis (Peto odds ratio = 3.99, 95% confidence interval = 2.20-7.22) in patients with spastic equinus foot. The botulinum toxin group also presented better results in the subjective assessment than the placebo group (Peto odds ratio = 3.49, 95% confidence interval = 1.50-8.12). Adverse events were more frequently observed after the use of botulinum toxin type A, but they were considered mild and self-limited.

Adolescent↗

Peripheral neuropathy in patients with hepatitis virus C infection in the Amazon region.

INTRODUCTION: Hepatitis virus C (HCV) infection is considered a health problem in the State of Acre localized in the Brazilian Amazon which has a prevalence rate of 5.9%. Peripheral neuropathy is a common extra-hepatic manifestation in patients with HCV. OBJECTIVE: To determine the prevalence of peripheral neuropathies using clinical and neurophysiological parameters. METHOD: A cross sectional study was performed in patients assisted by a specialized center of infectious diseases in the State of Acre. All patients completed a clinicoepidemiological questionnaire, physical examination and nerve conduction studies (NCS). RESULTS: We studied 78 patients with mean age 45.5 years (range from 10 to 76 years), two thirds were male, 51% had at least 8 years of formal education and 96% lived in the capital city of Acre State. Roughly 34% of patients complained about paresthesias mainly in upper limbs. The NCS diagnosed multiple mononeuropathy in 11 (14.1%; IC95% 7.6-23.2) patients and carpal tunnel syndrome in 4 (5.1%) patients. CONCLUSION: Subclinical involvement of peripheral nerves seems common in patients with HCV, with multiple mononeuropathy the main manifestation of nerve injury in this region as suggested by electrophysiological studies.

Adolescent↗

Clinical and epidemiological profile of multiple sclerosis in a reference center in the State of Bahia, Brazil.

Multiple sclerosis (MS) is an autoimmune, demyelinating and degenerative disease that affects the central nervous system. Its prevalence and clinical aspects vary according to the continent considered, being more frequent in Caucasians and young individuals aged 20 to 40 years. Epidemiological data from Brazil show that prevalence is variable, being more frequent in the Southern and Southeastern areas of the country, rather than in the Northern and Northeastern areas. The purpose of this paper is to describe MS clinical and epidemiological features in the State of Bahia, in the Brazilian Northeastern region. Thus, we held a cross-sectional study over the period from February to May, 2005, in the Multiple Sclerosis Patient Support Center ("Núcleo de Apoio aos Pacientes com Esclerose Múltipla") of Bahia, which included all patients with a diagnosis of MS seen over this period of time. A total of 121 patients were investigated, being 80.2% females (female:male ratio=4:1), with higher frequency in mulatto individuals (64%), and the relapsing-remitting type (91.3%). Most patients (68.7%) had mild MS, and blacks were prone to worse prognosis compared to other patients.

Adolescent↗

[Atrial septal defects as a risk factor for migraine: a case-control study].

To determine the magnitude of the association between atrial septal defect (ASD) and migraine. We evaluated 101 subjects submitted to transesophageal echocardiography (TEE). They have been asked about headache. Migraine diagnosis was established according the criteria of the International Headache Society (IHS). The subjects were match in cases (ASD carrier) and controls (without ASD). We analyzed the occurrence of migraine, of aura and the frequency of crises in the last month by chi-square test. We matched 34 cases and controls: 82.4% female, the mean age, in years was 38.7 (+/-11.24) and 38.9 (+/-11.17)). Migraine occurred in 79.4% of the cases and in 55.9% of the controls (OR = 4.3) CI = 95% (1.04-8.8), (p = 0.038). Aura occurred in 65.1% (cases) and 40% (controls). It was observed more than three migraine crises in the last month in 76.7% of the cases and 60% of the controls (OR = 1.56) (p = 0.2) (95% CI, 0.6 to 7.6). ASD is a risk factor to migraine with aura in the sample studied. ASD apparently increase the frequency of migraine crises.

Adolescent↗

[Cysticercosis research in epileptic patients dwelling in towns of the western Cariri in the State of Paraíba, Brazil].

This research involved a sample of 110 epileptic patients from western Cariri, Paraíba, Brazil and it has been developed in three successive phases. During the first one, an epidemiological form was applied with the aim of identifying risk factors related to the taeniasis cysticercosis complex in the etiology of the patients' epilepsy. The second phase consisted of immunological exams of 110 patients, by means of the EITB technique to identify the anti-cysticerci serum antibodies, whereas the presence of circulating antigens was verified through the ELISA technique. In the third phase, thirteen patients who were seropositive, were submitted to brain CT scan. Applying the questionnaire enabled us to know some risk factors. The seroprevalence detected was 118.2/1000 inhabitants. Out of the 13 seropositive patients for cysticercosis, 46.1% presented parenchymal cysticercotic damage. Based on these results, we are able to conclude that the studied towns reveal an epidemiological profile which is compatible with the occurrence of the taeniasis cysticercosis complex and cysticercosis plays an important role in the sprouting of epilepsy in these patients.

Adolescent↗

Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis.

Muscle over-activity is one of the cardinal features of spasticity and it is a common disability of stroke patients. In this group, spasticity is responsible for several limitations that interfere in their daily activities and quality of life. To treat spasticity, neurologists usually prescribe drugs as baclofen, tizanidine or benzodiazepines or even use definitive treatment as phenol or surgery. Authors suggest the use of botulinum toxin type A (BTX-A) for spasticity in the upper limbs after stroke, but there are few papers with adequate methodology supporting this idea. In this article we summarize the data of previous double-blind, randomised clinical trials to asses, with a meta-analysis, if BTX-A is an adequate treatment for spasticity due to stroke. The results show a statistical superiority of BTX-A ov%r placebo on reducing muscle tone by the Modified Ashworth Scale (WMD= 0.95 [0.74 to 1.17]) in patients with post-stroke upper limb spasticity.

Botulinum Toxins, Type A↗

17p duplicated Charcot-Marie-Tooth 1A: characteristics of a new population.

The most frequent type of Charcot-Marie-Tooth (CMT) neuropathy is that associated with the 17p11.2-p12 chromosome duplication, whose characteristics have been well described in European and North American populations. In this study, we analyzed a Brazilian population exhibiting the mutation, found in 57 patients from 42 families (79%) of a cohort of 53 families with demyelinating CMT. Almost 20% of the duplicated cases were sporadic. In 77% of the duplicated families the mutation event occurred in the hot spot area of the CMT1A-Rep region. Forty-five percent of patients were females, 84% were Caucasians and 13% of African descent. Distal limb weakness was the most frequent abnormality, appearing in 84% of patients, although uncommon manifestations such as severe proximal weakness, floppy baby syndrome, diaphragmatic weakness and severe scoliosis were also observed. One patient was wheelchair-bound, and three suffered severe hand weakness. Sensory abnormalities were detected in 84% of the cases, but 80% were unaware of this impairment. Twelve patients complained of positive sensory manifestations such as pain and paresthesias. Progression was reported by 40%. Motor conduction velocities in the upper limbs were always less than 35 m/s, and less than 30.4 m/s in the peroneal nerve. The findings of this study expand the clinical spectrum of the disease.

Adolescent↗

Intra-hospital lethality among infants with pyogenic meningitis.

Predictor variables of intra-hospital lethality among infants with pyogenic meningitis due to Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae were identified using data from a follow-up study of infants with bacterial meningitis. The infants who were admitted to Couto Maia Hospital from March 1, 1997 to December 31, 1997 presenting with symptoms of bacterial meningitis were identified and included in a database. An analysis of the clinical and laboratory information was performed using EPI info 6.01b and SPSS 6.1 statistical programs. The total mortality rate was 17.1%, and the majority of deaths occurred within 48 hours of hospitalization. Factors associated most frequently with poor outcome included absence of respiratory infection, high cerebrospinal fluid protein, and compromised cranial nerves. Early identification of major risk groups is important to adopt measures to improve prognosis.

Cerebrospinal Fluid Proteins↗

[Anthropometric cranial measures of normal newborn].

OBJECTIVE: The study has been carried out through anthropometric measures of Bahian newborns, to define measures according with the reality of this region. METHOD: Study type transversal cut in term babies with the measures of cephalic perimeter, biauricular and anteroposterior distances, fontanel and cephalic index. RESULTS: 388 babies, 204 (52.6%) of males and 184 (47.4%) females had been evaluated. The cephalic perimeter varied between 31.0 and 38.0 cm, with 34.4 +/- 1.2 average. The cephalic index varied between 0.75 and 1.06, with 0.91 +/- 0.05 average. CONCLUSION: The anthropometric measures are surveyed aiming at precocious detention of anomalies. Possibly, these measures can be influenced by racial factors; however, the measures carried through in Brazil follow values of foreign authors. Thus, the study shows data of a Northeastern region and points out the importance of the accomplishment of multicentric studies.

Body Weight↗

[Audiologic late prognosis due to meningitis in children].

INTRODUCTION: Auditory deficit has been considered one of the main late manifestations of meningitis, when it occurs during the two first years of life. Few studies have been conducted in Brazil explaining the evolution of children who had meningitis and the percentage, as well the neurological gravity, the auditory problems and sequels after the children left the hospital. OBJECTIVE: To characterize the main auditory and neurological correlation, delineating the profile of the auditory deficits found five years after the central nervous system infection. METHOD: We evaluated children between 5 and 7 years old, admitted in Couto Maia Hospital in the year of 1997, that had been diagnosed with meningitis at an age of two years or below. RESULTS: 19 children passed through the neurological and auditory evaluation. The average age was 6 years and 68.42% were male. In relation to etiology, 52.63% pyogenic, 42.1% viral, 5.26% due to tuberculosis. Auditory alterations had occurred in 26.31% of this population. CONCLUSION: Auditory problems cause academic and social implications in the affected children, especially those of school age. We confirmed the necessity of audiologic following of all children with previous history of meningitis.

Age Distribution↗

Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers.

BACKGROUND: A small fraction of Human T cell Leukemia Virus type-1 (HTLV-I) infected subjects develop a severe form of myelopathy. It has been established that patients with HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) show an exaggerated immune response when compared with the immunological response observed in HTLV-I asymptomatic carriers. In this study the immunological responses in HAM/TSP patients and in HTLV-I asymptomatic carriers were compared using several immunological assays to identify immunological markers associated with progression from infection to disease. METHODS: Immunoproliferation assays, cytokine levels of unstimulated cultures, and flow cytometry analysis were used to evaluate the studied groups. Nonparametric tests (Mann-Whitney U test and Wilcoxon matched-pairs signed ranks) were used to compare the difference between the groups. RESULTS: Although both groups showed great variability, HAM/TSP patients had higher spontaneous lymphoproliferation as well as higher IFN-gamma levels in unstimulated supernatants when compared with asymptomatic carriers. Flow cytometry studies demonstrated a high frequency of inflammatory cytokine (IFN-gamma and TNF-alpha) producing lymphocytes in HAM/TSP as compared to the asymptomatic group. This difference was accounted for mainly by an increase in CD8 cell production of these cytokines. Moreover, the HAM/TSP patients also expressed an increased frequency of CD28-/CD8+ T cells. Since forty percent of the asymptomatic carriers had spontaneous lymphoproliferation and IFN-gamma production similar to HAM/TSP patients, IFN-gamma levels were measured eight months after the first evaluation in some of these patients to observe if this was a transient or a persistent situation. No significant difference was observed between the means of IFN-gamma levels in the first and second evaluation. CONCLUSIONS: The finding that a large proportion of HTLV-I carriers present similar immunological responses to those observed in HAM/TSP, strongly argues for further studies to evaluate these parameters as markers of HAM/TSP progression.

Adult↗

Cerebral infarction in autopsies of chagasic patients with heart failure.

OBJECTIVE: To determine the frequency of encephalic infarction and its contribution to lethality in patients with Chagas' disease and heart failure. METHODS: Medical records and autopsy reports of patients with Chagas' disease complicated by heart failure, who died at the Professor Edgar Santos Hospital of the Federal University of Bahia in the past 45 years were retrospectively analyzed. Data comprised information regarding the clinical history on hospital admission, complementary and anatomicopathological examinations, including the presence of encephalic infarction, the impaired region, and the cause of death. RESULTS: Of the 5,447 autopsies performed, 524 were in patients with heart failure due to Chagas' disease. The mean age was 45.7 years, and 51 (63%) patients were of the male sex. The frequency of encephalic infarction was 17.5%, corresponding to 92 events in 92 individuals, 82 (15.8%) of which involved the brain, 8 (1.5%) involved the cerebellum, and 2 (0.4%) involved the hypophysis. CONCLUSION: Cerebral infarction has been a frequent finding in autopsies of chagasic patients with heart failure, and it has been an important cause of death in our region. The presence of cerebral infarction and its complications have been associated with death in 52% of the cases studied.

Adolescent↗

[Vectorial transmission of Chagas' disease in Mulungu do Morro, Northeastern of Brazil].

A serological survey was carried out to determine the prevalence of Chagas' disease in municipality. The following variables were analyzed to identify the form of transmission of this disease: age, sex, clinical and transfusional history, degree of kinship and serology. Within the 863 municipalities we studied, we identified 265 individuals, with serology testing done on them and on their respective mothers. Of these, 232 tested negative serology for Chagas'disease and 33 (14.2%) positive. We found 9 (3.9%) patients, of 14.3 years. average age with vectorial transmission and 24 (10.3%), of 26.6 years. average age with probable, vertical and vectorial transmission. When we compare the two groups in regard to age averages and manner of transmission of Trypanosoma cruzi, we encounter a statistical significance. Our results suggest the existence of an active, vectorial transmission of Trypanosoma cruzi in Mulungu do Morro.

Adolescent↗

Taeniasis and cysticercosis prevalence in a small village from Northeastern Brazil.

UNLABELLED: Although not considered as an endemic region, the Northeast of Brazil has the necessary conditions for the development of taeniasis-cysticercosis complex. In a previous paper, we demonstrated that Mulungu do Morro municipality, in the State of Bahia, has a high seroprevalence to cysticercosis in epileptic patients. OBJECTIVE: to determine the prevalence of taeniasis and positive cysticercosis serology in the population of Mulungu do Morro. METHOD: blood and stool samples were collected from a random sampling of the population, by family. The identification of antibodies against T. solium cysticerci was made by EITB and T. solium antigens were identified using a polyclonal antibody-capture ELISA. RESULTS: the cysticercosis seroprevalence was 1.6% (C.I. = 0.8 to 2.8%) and the taeniasis prevalence 4.5% (C.I. = 3.0 to 6.5%). Seropositivity to cysticercosis was higher among those who lived in a house of a person testing positive for coproantigen, p=0.017. CONCLUSION: our results demonstrate that the taeniasis-cysticercosis complex is endemic in Mulungu do Morro. We believe that all areas in the world with the same socio-economic and sanitary characteristics are likely to have high prevalence of this parasite.

Adolescent↗

Prevalence of Chagas' disease in Mulungu do Morro northeastern Brazil.

OBJECTIVE: The aim of this paper is to describe the prevalence of T. Cruzi infection in patients of from Mulungu do Morro, a rural tropical region of Northeastern Brazil. METHODS: A cross-sectional study was performed. After randomly selecting samples of the population, and obtaining their consents, patients completed pretested epidemiological and clinical questionnaires. Serum samples from all patients were collected and screened for the presence of T. cruzi antibodies. RESULTS: Of 694 patients examined, 174 patients (25.1%) tested had a positive serology for Chagas' disease. Of the study population, 341 patients were male with 27% Chagas' disease prevalence, without a statistical difference. Illiteracy was the only variable related to T. cruzi infection in our population. CONCLUSION: In conclusion, our study points to the high prevalence of Chagas' disease among patients in Mulungu do Morro, suggesting that this region has a high frequency of infection and probably active vectorial transmission.

Adolescent↗

[Clinical and laboratory features of aseptic meningitis associated with measles-mumps-rubella vaccine].

OBJECTIVE: To describe epidemiological, clinical, and cerebrospinal fluid (CSF) findings in cases of aseptic meningitis associated with measles-mumps-rubella vaccination following a mass immunization campaign in the Brazilian state of Bahia in August 1997 promoted by the country's Ministry of Health, and to compare these cases to the cases of aseptic meningitis not associated with the vaccine that occurred in the same year. METHODS: Between March 1997 and October 1997, all individuals between 1 and 12 years of age admitted to the Couto Maia Hospital (the Bahia reference hospital for infectious illnesses) with a clinical and laboratory diagnosis of aseptic meningitis were prospectively followed. The study population was divided into two groups: one with individuals who had received the vaccine, and one with individuals who had not received the vaccine. Demographic, clinical, and laboratory information was collected on both groups. RESULTS: In September, following the vaccination campaign, 74 cases of aseptic meningitis were registered at the Couto Maia Hospital, versus the monthly average of 7.5 cases. We observed a greater frequency of nuchal rigidity and increased CSF cellularity among children whose meningitis was associated with the vaccine. However, encephalitic involvement was more frequent in the group of children with non-vaccinal meningitis. CONCLUSIONS: Although the course of post-vaccinal meningitis is more benign than that of other forms of the disease, its treatment generates costs related to ancillary exams and hospitalizations. Mass vaccination campaigns should employ less reactogenic vaccine strains.

Child↗